3 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| TripSit | Pharmacology | DrugCentral | ||
|---|---|---|---|---|
| Classification | ||||
| Class / category | — | — | ||
| Also known as | preludin | — | — | |
| Safety | ||||
| Dose · Oral | ||||
| Common | 25–50 mg | — | — | |
| Duration | ||||
| Onset | 15–30 minutes | — | — | |
| Total | 4–8 hours | — | — | |
| After-effects | 1–12 hours | — | — | |
| Pharmacology | ||||
| Receptor activity | — | — | SLC6A3SLC6A2MAOA | |
| Half-life | — | 16 to 31 hours Following oral admin of a single 75 mg dose as conventional tablets, phenmetrazine has a plasma half life of about 8 hr in healthy adults. /Phenmetrazine hydrochloride/ | — | |
TripSit summary
Stimulant drug that was previously used as an appetite suppresant, has been withdrawn from the market, due to concerns of abuse and addiction. Usually produces less nervousness, euphoria, and insomnia than drugs of the amphetamine family. Also as a study concluded, it is slightly more effective than dextroamphetamine as a weight loss agent.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.